TABRECTA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0078-0716
  • Package NDC 0078-0716-56
  • Package NDC 0078-0716-94
  • Application number NDA213591
  • SPL ID 307ab7c9-76d7-47cf-9b7e-38fcbd1b3671
  • SPL set ID 455892c3-d144-4ba8-9ab4-79cabff9876d
  • UNII C2A374O70X
  • RxCUI 2362234
  • RxCUI 2362240
  • RxCUI 2362242
  • RxCUI 2362244

What the source publishes

Labeler
Novartis Pharmaceuticals Corporation
Active ingredients
capmatinib
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0078-0716_307ab7c9-76d7-47cf-9b7e-38fcbd1b3671
{
  "name": "TABRECTA",
  "splId": "307ab7c9-76d7-47cf-9b7e-38fcbd1b3671",
  "labels": [
    {
      "setId": "455892c3-d144-4ba8-9ab4-79cabff9876d",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=455892c3-d144-4ba8-9ab4-79cabff9876d",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=455892c3-d144-4ba8-9ab4-79cabff9876d"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Novartis Pharmaceuticals Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56)",
      "package_ndc": "0078-0716-56",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200506"
    },
    {
      "sample": true,
      "description": "56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94)",
      "package_ndc": "0078-0716-94",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200506"
    }
  ],
  "productId": "0078-0716_307ab7c9-76d7-47cf-9b7e-38fcbd1b3671",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "0078-0716",
  "deaSchedule": null,
  "genericName": "capmatinib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CAPMATINIB HYDROCHLORIDE",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "NDA213591",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200506",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "C2A374O70X"
    ],
    "rxcui": [
      "2362234",
      "2362240",
      "2362242",
      "2362244"
    ],
    "spl_set_id": [
      "455892c3-d144-4ba8-9ab4-79cabff9876d"
    ],
    "manufacturer_name": [
      "Novartis Pharmaceuticals Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0078-0716_307ab7c9-76d7-47cf-9b7e-38fcbd1b3671"